Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

TODD M ANTIN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1598714073
CMS profile
253197
Location
DECATUR, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$194,421.63

384 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 4 of 8; records 151–200 of 384 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

TODD M ANTIN

NPI 1598714073 · CMS profile ID 253197

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

DECATUR, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 8; records 151–200 of 384 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1598714073?year=2019&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
TODD M ANTIN, NPI 1598714073, CMS profile ID 253197. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 8; records 151–200 of 384 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1598714073?year=2019&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). TODD M ANTIN, NPI 1598714073, CMS profile ID 253197. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 8; records 151–200 of 384 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1598714073?year=2019&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
TODD M ANTIN, NPI 1598714073, CMS profile ID 253197, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 8; records 151–200 of 384 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1598714073?year=2019&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

384 matching records · $194,421.63 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 384 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 384.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Neurocrine Biosciences, Inc. $1,100.0006/18/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693112025 CMS
Teva Pharmaceuticals USA, Inc. $1.0206/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697715025 CMS
Teva Pharmaceuticals USA, Inc. $5.4806/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697715027 CMS
Shire North American Group Inc $16.6906/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637781775 CMS
Allergan Inc. $4.2506/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670041255 CMS
Allergan Inc. $6.9106/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670041259 CMS
Otsuka America Pharmaceutical, Inc. $44.0806/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 687345617 CMS
Sunovion Pharmaceuticals Inc. $14.4006/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688048697 CMS
Neurocrine Biosciences, Inc. $1,100.0006/10/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693112023 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.5706/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681873847 CMS
Takeda Pharmaceuticals U.S.A., Inc. $0.3306/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682006787 CMS
Teva Pharmaceuticals USA, Inc. $1.6806/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697712013 CMS
Teva Pharmaceuticals USA, Inc. $1.1306/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697799385 CMS
Avanir Pharmaceuticals, Inc. $16.4806/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 653589195 CMS
Avanir Pharmaceuticals, Inc. $44.8006/04/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 653589455 CMS
Neurocrine Biosciences, Inc. $1,100.0006/04/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693112021 CMS
Otsuka America Pharmaceutical, Inc. $20.0006/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 687345615 CMS
Teva Pharmaceuticals USA, Inc. $324.7206/04/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697881781 CMS
Teva Pharmaceuticals USA, Inc. $942.0006/04/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697881783 CMS
Avanir Pharmaceuticals, Inc. $2,010.0006/03/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 653589459 CMS
Janssen Pharmaceuticals, Inc $11.1406/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658271873 CMS
Neurocrine Biosciences, Inc. $1,100.0006/03/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693112019 CMS
Teva Pharmaceuticals USA, Inc. $2,020.0006/03/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697881789 CMS
Teva Pharmaceuticals USA, Inc. $1,263.0006/03/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697881791 CMS
Teva Pharmaceuticals USA, Inc. $101.0506/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697881811 CMS
Janssen Pharmaceuticals, Inc $16.7905/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658271871 CMS
Teva Pharmaceuticals USA, Inc. $3,283.0005/31/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697881779 CMS
Avanir Pharmaceuticals, Inc. $98.4305/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 653589457 CMS
Sunovion Pharmaceuticals Inc. $16.3605/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688048699 CMS
Avanir Pharmaceuticals, Inc. $44.0805/29/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 653590479 CMS
Avanir Pharmaceuticals, Inc. $1,460.0005/29/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 653590705 CMS
Lundbeck LLC $10.3705/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684279139 CMS
Teva Pharmaceuticals USA, Inc. $14.2505/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697710417 CMS
Teva Pharmaceuticals USA, Inc. $8.5505/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697821599 CMS
Allergan Inc. $16.5105/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670041245 CMS
Allergan Inc. $5.8005/24/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670041249 CMS
Allergan Inc. $1,920.0005/24/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670041253 CMS
Avanir Pharmaceuticals, Inc. $28.5105/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 653590477 CMS
Janssen Pharmaceuticals, Inc $1,900.0005/22/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658271867 CMS
Janssen Pharmaceuticals, Inc $41.3205/22/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658271869 CMS
Allergan Inc. $18.1105/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670041233 CMS
Allergan Inc. $3.4805/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670041237 CMS
Allergan Inc. $1,920.0005/21/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670041241 CMS
Avanir Pharmaceuticals, Inc. $2,010.0005/21/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 653589465 CMS
Avanir Pharmaceuticals, Inc. $2,010.0005/21/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 653589715 CMS
Janssen Pharmaceuticals, Inc $13.5605/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658271865 CMS
Otsuka America Pharmaceutical, Inc. $55.6805/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 687345613 CMS
Teva Pharmaceuticals USA, Inc. $4.5405/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697709619 CMS
Teva Pharmaceuticals USA, Inc. $201.3805/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697881741 CMS
Teva Pharmaceuticals USA, Inc. $598.2605/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697881785 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $194,421.63 384
PY2020 $100,767.91 269
PY2021 $152,089.23 365
PY2022 $127,587.28 296
PY2023 $113,966.72 230
PY2024 $165,492.92 254
PY2025 $164,814.66 217

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Principal investigator $60,245.20 20
PY2021 Principal investigator $93,566.70 30
PY2020 Principal investigator $9,750.00 2
PY2019 Principal investigator $8,774.00 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

20 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 LivaNova USA, Inc. $1,000.00 11/18/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 942164655
Principal investigator 1 LivaNova USA, Inc. $600.00 11/03/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 942164661
Principal investigator 1 LivaNova USA, Inc. $216.00 10/26/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 942164725
Principal investigator 1 LivaNova USA, Inc. $1,474.80 09/09/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164623
Principal investigator 1 LivaNova USA, Inc. $6,487.20 09/07/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164617
Principal investigator 1 LivaNova USA, Inc. $3,429.60 07/27/2022 Non-covered Recipient Entity
PACT Atlanta, LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942168147
Principal investigator 1 LivaNova USA, Inc. $108.00 06/09/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
The RECOVERsUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes No dispute reported 06/30/2026 942164521
Principal investigator 1 LivaNova USA, Inc. $6,643.20 06/02/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
The RECOVERsUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes No dispute reported 06/30/2026 942164513
Principal investigator 1 LivaNova USA, Inc. $6,475.20 05/05/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
The RECOVERsUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes No dispute reported 06/30/2026 942164517
Principal investigator 1 LivaNova USA, Inc. $3,350.40 03/31/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164455
Principal investigator 1 LivaNova USA, Inc. $2,001.60 03/17/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164435
Principal investigator 1 LivaNova USA, Inc. $5,812.80 03/10/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164419
Principal investigator 1 LivaNova USA, Inc. $28.80 03/03/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164409
Principal investigator 1 LivaNova USA, Inc. $3,369.60 02/23/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164445
Principal investigator 1 LivaNova USA, Inc. $268.80 02/17/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164429
Principal investigator 1 LivaNova USA, Inc. $2,049.60 02/10/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164415
Principal investigator 1 LivaNova USA, Inc. $3,632.40 02/03/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164405
Principal investigator 1 LivaNova USA, Inc. $805.20 01/25/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164451
Principal investigator 1 LivaNova USA, Inc. $1,048.80 01/20/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164441
Principal investigator 1 LivaNova USA, Inc. $11,443.20 01/12/2022 Non-covered Recipient Entity
PACT ATLANTA LLC
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 942164425